Display options
Share it on

Eur J Hum Genet. 2009 Nov;17(11):1501-6. doi: 10.1038/ejhg.2009.63. Epub 2009 Apr 29.

The role of mitochondrial genome in essential hypertension in a Chinese Han population.

European journal of human genetics : EJHG

Hai-Yan Zhu, Shi-Wen Wang, Lisa J Martin, Li Liu, Yan-Hua Li, Rui Chen, Lin Wang, Min-Lu Zhang, D Woodrow Benson

Affiliations

  1. General Hospital of Chinese PLA, Beijing, China.

PMID: 19401720 PMCID: PMC2986694 DOI: 10.1038/ejhg.2009.63

Abstract

Earlier genetic studies of essential hypertension have focused on nuclear genes or family-based mitochondrial screening in Caucasian and African-American pedigrees. The role of mitochondria in sporadic Chinese hypertensives is unknown. We sequenced mitochondrial genomes in 306 age- and gender-balanced Chinese Han hypertensives and controls. In 153 hypertensives, putative functional changes included 4 changes in rRNA genes, 11 changes in tRNA genes and 25 amino-acid substitutions. The remaining variants were synonymous changes or non-coding regions. In the 153 controls, 2 base changes in the tRNA genes and 13 amino-acid substitutions were found. A8701G in ATP6 gene (belongs to haplogroup M; P=0.0001) and C8414T in ATP8 gene (belongs to haplogroup D; P=0.01) were detected significantly different in the cases and controls. Interestingly, the cases were more likely to have two or more amino-acid changes and RNA variants compared with the controls (57.43 versus 23.81%, P=0.0001). In addition, several variants we found were highly conserved and/or specifically located at the 3' end adjacent to the anticodon, which may contribute to the stabilization of structure, and thus lead to the decrease of tRNA metabolism. In conclusion, mitochondrial SNPs (mtSNPs) may affect the course of hypertension in sporadic Chinese hypertensives. Some specific mtSNP within mitochondria may have potential role in the Chinese hypertensives due to their function. Synergetic interaction between mitochondrial mtSNPs and/or haplogroups is needed to be investigated in the future.

References

  1. Am J Hypertens. 2004 Sep;17(9):852-60 - PubMed
  2. Science. 1999 Mar 5;283(5407):1482-8 - PubMed
  3. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D749-51 - PubMed
  4. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1661-7 - PubMed
  5. Lancet. 2003 Jun 21;361(9375):2118-23 - PubMed
  6. Am J Hum Genet. 2002 May;70(5):1152-71 - PubMed
  7. Hypertens Res. 2007 Jun;30(6):513-20 - PubMed
  8. Eur J Hum Genet. 2004 Dec;12(12):1080-2 - PubMed
  9. Mitochondrion. 2007 Feb-Apr;7(1-2):72-9 - PubMed
  10. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8739-46 - PubMed
  11. Curr Opin Cardiol. 2001 May;16(3):201-10 - PubMed
  12. Blood Press Monit. 2007 Aug;12(4):207-13 - PubMed
  13. Circulation. 2007 Mar 13;115(10):1269-74 - PubMed
  14. Nature. 1981 Apr 9;290(5806):457-65 - PubMed
  15. Hypertension. 1994 Jul;24(1):63-9 - PubMed
  16. Mitochondrion. 2005 Feb;5(1):15-33 - PubMed
  17. Pharmacogenet Genomics. 2007 Nov;17(11):931-9 - PubMed
  18. J Hypertens. 2007 Oct;25(10):2067-73 - PubMed
  19. Science. 2004 Nov 12;306(5699):1190-4 - PubMed
  20. JAMA. 2003 May 21;289(19):2560-72 - PubMed
  21. Hypertens Res. 2002 Nov;25(6):857-64 - PubMed
  22. PLoS Genet. 2006 Aug;2(8):e128 - PubMed
  23. Circulation. 2000 Oct 17;102(16):1956-63 - PubMed
  24. Brain. 2000 Sep;123 ( Pt 9):1896-902 - PubMed
  25. Hum Genet. 2007 Feb;120(6):827-36 - PubMed
  26. Lancet. 2003 Jun 21;361(9375):2149-51 - PubMed
  27. Hum Biol. 1981 Sep;53(3):453-66 - PubMed
  28. Clin Genet. 2001 Jul;60(1):13-21 - PubMed
  29. Nucleic Acids Res. 2007 Jan;35(Database issue):D823-8 - PubMed

MeSH terms

Publication Types

Grant support